Shaanxi Micot Pharmaceutical Technology Co., Ltd.

HK$18.81As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2335Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$6.240B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$21
11.60%
(73.20%)
Hold 11|10|10|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.43
0.46
0.50
0.52
7.23%
8.33%
23.15%
16.10%
Revenue¥M
426.9
445.0
456.1
449.2
3.40%
10.91%
10.89%
8.15%
Peers (US$796.0M)
Cap (US$)
PE
807.2M
496.4x
796.2M
—
Capital
TTM
5Y
10Y
Leveragex
2.974
(0.689)
(0.500)
EBIT/Intx
1.167
0.124
0.142
Own earn%
(12.77)
39.14
31.24
Sh yield%
40.56
18.40
18.28
Owners
Insiders/Inst%
11.98
35.35
Short interest%
1.76
SBC / revenue%
4.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
3–10
$1 testx
—
Incr. ROIC%
4